-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HPYds+/3sBQ090BxiX1//suPqZeixYsosZNrfgVp0i05zb7qRBxGTFNNN4og0XB4 ToGaVqlxV46GJ8Ee5f9ZbA== 0000905718-00-000082.txt : 20000215 0000905718-00-000082.hdr.sgml : 20000215 ACCESSION NUMBER: 0000905718-00-000082 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BIONX IMPLANTS INC CENTRAL INDEX KEY: 0001030418 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 223458598 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: SEC FILE NUMBER: 005-50957 FILM NUMBER: 542561 BUSINESS ADDRESS: STREET 1: 279B GREAT VALLEY PKWY CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 6102960919 MAIL ADDRESS: STREET 1: 279B GREAT VALLEY PARKWAY CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: BIONIX INC DATE OF NAME CHANGE: 19970109 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: WALL TERENCE D CENTRAL INDEX KEY: 0001027497 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: VITAL SIGNS INC STREET 2: 20 CAMPUS ROAD CITY: TOTOWA STATE: NJ ZIP: 07512 MAIL ADDRESS: STREET 1: DIALOGIC CORP STREET 2: 1515 ROUTE 10 CITY: PARSIPPANY STATE: NJ ZIP: 07054 SC 13G/A 1 SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2)* BIONX IMPLANTS, INC. - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock - -------------------------------------------------------------------------------- (Title of Class of Securities) 09064Q106 - -------------------------------------------------------------------------------- (CUSIP Number) August 13, 1999 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule 13G is filed: [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [X] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP NO. 09064Q106 - -------------------------------------------------------------------------------- (1) Names of Reporting Persons. I.R.S. Identification Nos. of Above Persons (entities only): Terence D. Wall - -------------------------------------------------------------------------------- (2) Check the Appropriate Box if a Member of a Group (See Instructions) (a) (b) - -------------------------------------------------------------------------------- (3) SEC Use Only - -------------------------------------------------------------------------------- (4) Citizenship or Place of Organization: United States - -------------------------------------------------------------------------------- Number of Shares Beneficially Owned by (5) Sole Voting Each Reporting Person With Power: 2,572,467* (6) Shared Voting Power: -- (7) Sole Dispositive Power: 2,572,467* (8) Shared Dispositive Power: -- - -------------------------------------------------------------------------------- (9) Aggregate Amount Beneficially Owned by Each Reporting Person: 2,572,467* - -------------------------------------------------------------------------------- (10) Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) - -------------------------------------------------------------------------------- (11) Percent of Class Represented by Amount in Row (9): 28.0%* - -------------------------------------------------------------------------------- (12) Type of Reporting Person (See Instructions): IN - -------------------------------------------------------------------------------- * Mr. Terence D. Wall beneficially owns 2,572,467 shares of Bionx Implants, Inc. common stock ("Common Stock"), which includes 3,750 shares of Common Stock which Mr. Wall has the right to acquire upon conversion of options granted by the Issuer within 60 days after December 31, 1999. All of Mr. Wall's shares of Common Stock are held in an investment partnership which he controls. 484,421 of such shares of Common Stock represent Mr. Wall's proportionate equity interest in 2,684,211 shares of Common Stock owned by Bionix, B.V., a Dutch company. Pursuant to an agreement with Bionix, B.V., Mr. Wall has the right to cause Bionix, B.V. to transfer to him such 484,421 shares. Item 1(a). Name of Issuer: Bionx Implants, Inc. - -------------------------------------------------------------------------------- Item 1(b). Address of Issuer's Principal Executive Offices: 1777 Sentry Parkway West, Gwynedd Hall, Suite 400, Blue Bell, Pennsylvania 19422 - -------------------------------------------------------------------------------- Item 2(a). Name of Person Filing: Terence D. Wall - -------------------------------------------------------------------------------- Item 2(b). Address of Principal Business Office or, if none, Residence: 20 Campus Road, Totowa, New Jersey 07512 - -------------------------------------------------------------------------------- Item 2(c). Citizenship: United States - -------------------------------------------------------------------------------- Item 2(d). Title of Class of Securities: Common Stock - -------------------------------------------------------------------------------- Item 2(e). CUSIP No.: 09064Q106 - -------------------------------------------------------------------------------- Item 3. If This Statement Is Filed Pursuant to ss.240.13d-1(b) or 240.13d-2(b) or (c), check whether the Person Filing is a (a) [ ] Broker or Dealer registered under Section 15 of the Act (15 U.S.C. 78o); (b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) [ ] Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c); (d) [ ] Investment Company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8); (e) [ ] An Investment Adviser in accordance with ss.240.13d-1(b)(1)(ii) (E); (f) [ ] An Employee Benefit Plan or Endowment Fund in accordance with ss.240.13d-1(b)(1)(ii)(F); (g) [ ] A Parent Holding Company or control person in accordance with ss.240.13d-1(b)(1)(ii)(G); (h) [ ] A Savings Associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A Church Plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] Group, in accordance with ss.240.13d-1(b)(1)(ii)(J). Item 4. Ownership (a) Amount Beneficially Owned (as of December 31, 1999): 2,572,467* (b) Percent of Class (as of December 31, 1999): 28.0%* (c) Number of Shares as to which such person has: (i) sole power to vote or to direct the vote 2,572,467* (ii) shared power to vote or to direct the vote -- ---------- (iii) sole power to dispose or to direct the disposition of 2,572,467* (iv) shared power to dispose or to direct the disposition of -- ---------- __________________ * Mr. Terence D. Wall beneficially owns 2,572,467 shares of Bionx Implants, Inc. common stock ("Common Stock"), which includes 3,750 shares of Common Stock which Mr. Wall has the right to acquire upon conversion of options granted by the Issuer within 60 days after December 31, 1999. All of Mr. Wall's shares of Common Stock are held in an investment partnership which he controls. 484,421 of such shares of Common Stock represent Mr. Wall's proportionate equity interest in 2,684,211 shares of Common Stock owned by Bionix, B.V., a Dutch company. Pursuant to an agreement with Bionix, B.V., Mr. Wall has the right to cause Bionix, B.V. to transfer to him such 484,421 shares. Item 5. Ownership of Five Percent or Less of a Class If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ]. Item 6. Ownership of More Than Five Percent on Behalf of Another Person. N/A Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. N/A Item 8. Identification and Classification of Members of the Group. N/A Item 9. Notice of Dissolution of Group. N/A Item 10. Certification. N/A SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 14, 2000 Terence D. Wall By: /s/ Laura R. Kuntz Laura R. Kuntz, Attorney-in-Fact* * A power of attorney was previously filed with the Commission and is incorporated herein by reference. Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001). -----END PRIVACY-ENHANCED MESSAGE-----